No black box warning on record for Tofidence

As of the latest FDA labeling reviewed, Tofidence (TOCILIZUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tofidence medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serious Infections – do not administer TOFIDENCE during an active infection, including localized infections. If a serious infection develops, interrupt TOFIDENCE until the infection is controlled. ( 5.1 ) Gastrointestinal (GI) perforation—use with caution in patients who may be at increased risk. ( 5.2 ) Hepatotoxicity- Monitor patients for signs and symptoms of hepatic

No black box warning on record for Tofidence

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serious Infections – do not administer TOFIDENCE during an active infection, including localized infections. If a serious infection develops, interrupt TOFIDENCE until the infection is controlled. ( 5.1 ) Gastrointestinal (GI) perforation—use with caution in patients who may be at increased risk. ( 5.2 ) Hepatotoxicity- Monitor patients for signs and symptoms of hepatic

Tofidence Black Box Warning

No black box warning on record for Tofidence

Other warnings & precautions

Tofidence Black Box Warning

No black box warning on record for Tofidence

Other warnings & precautions